Glucose Health, Inc.
GLUC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $1 | $1 |
| % Growth | -28.2% | -50.1% | 12.5% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $1 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 19.7% | 40.3% | 42.6% | 43% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $1 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $1 | $1 | $1 |
| Operating Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | -79.8% | -78.9% | -52.4% | -35.2% |
| Other Income/Exp. Net | -$0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$1 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | -82.3% | -78.9% | -52.4% | -35.5% |
| EPS | -0.025 | -0.029 | -0.045 | -0.026 |
| % Growth | 13.9% | 35.2% | -72.6% | – |
| EPS Diluted | -0.025 | -0.029 | -0.045 | -0.026 |
| Weighted Avg Shares Out | 17 | 17 | 14 | 13 |
| Weighted Avg Shares Out Dil | 17 | 17 | 14 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$1 | -$0 |
| % Margin | -79.5% | -78.9% | -52.4% | -35.2% |